Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 31;17(1):212.
doi: 10.1186/s13023-022-02357-y.

Patient involvement in rare diseases research: a scoping review of the literature and mixed method evaluation of Norwegian researchers' experiences and perceptions

Gry Velvin  1 , Thale Hartman  2 , Trine Bathen  2
Affiliations

Patient involvement in rare diseases research: a scoping review of the literature and mixed method evaluation of Norwegian researchers' experiences and perceptions

Gry Velvin et al. Orphanet J Rare Dis. .

Abstract

Background: Patients' involvement (PI) in research is recognized as a valuable strategy for increasing the quality, developing more targeted research and to speed up more innovative research dissemination. Nevertheless, patient involvement in rare diseases research (PI-RDR) is scarce. The aims were: To study the Norwegian researchers` experiences and perceptions of PI-RDR and review the literature on PI-RDR.

Methods: 1. A systematic scoping review of the literature on PI-RDR. 2. A cross-sectional questionnaire study with close-ended and open-ended questions to investigate the researchers` experiences.

Results: In the scoping review 608 articles read in full-text and 13 articles (one review and twelve primary studies) were included. The heterogeneity of the design, methodology and results was large. Most studies described several benefits of PI, but few described methods for measuring impacts and effectiveness of PI-RDR. In the cross sectional part of this study, 145 of 251 employees working in the nine Norwegian Centers on Rare Diseases participated, of these 69 were researchers. Most (95%) of the researchers claimed that rare diseases research is more challenging than for the more common diseases. The majority (95%) argued that PI-RDR may increase the quality of the studies and the relevance, and most (89%) agreed that PI-RDR in dissemination may increase the awareness and public interest for rare diseases. In the open-ended questions several researchers also claimed challenges related to PI-RDR, and many had proposal for improving PI and promotion of rare disease research.

Conclusion: Both the literature and researchers emphasized that PI-RDR is important for improving research quality and increase the public attention on rare diseases, but what constitutes effective PI-RDR still remain unclear. More research on the design, methodology and assessment for measuring the impact of PI-RDR is warranted.

Keywords: Benefits; Challenges; Effectiveness; Impacts; Methodology; Patient involvement; Rare disease research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of search, screening and inclusion process of scoping review
Fig. 2
Fig. 2
Challenges in rare disease research
Fig. 3
Fig. 3
Is PI in rare disease research useless and demanding? (%)
Fig. 4
Fig. 4
The utility of PI in research dissemination
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nguengang WN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–173. doi: 10.1038/s41431-019-0508-0. - DOI - PMC - PubMed
    1. European Commission. Rare disorder definition 2019 (Available from: Rare diseases | Public Health (europa.eu).
    1. Gagnon C, Fortin J, Lamontage ME, Plourde A. Methodological framework for the development of practive guidelines and knowledge tools for rare diseases. J Neuromuscul Dis. 2021. The rare knowledge mining methodological framework for the development of practice guidelines and knowledge translation tools for rare diseases - PubMed (nih.gov). 10.3233/JND-200536. - PubMed
    1. Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J, et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet Rare Dis. 2018;13(1):16. doi: 10.1186/s13023-018-0810-x. - DOI - PMC - PubMed
    1. Somanadhan S, Nicholson E, Dorris E, Brinkley A, Kennan A, Treacy E, et al. Rare Disease Research Partnership (RAinDRoP): a collaborative approach to identify research priorities for rare diseases in Ireland. HRB Open Res. 2020;3:13. doi: 10.12688/hrbopenres.13017.2. - DOI - PMC - PubMed

Publication types